Article Text

Download PDFPDF

Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions
  1. K Vosa,
  2. P Steenbakkersd,
  3. A M M Miltenburgd,
  4. E Bosd,
  5. M W van den Heuvele,
  6. R A van Hogezandc,
  7. R R P de Vriesb,
  8. F C Breedvelda,
  9. A M H Bootsd
  1. aDepartment of Rheumatology, LUMC, Leiden, The Netherlands, bDepartment of Immunohaematology and Blood Bank, LUMC, Leiden, cDepartment of Hepato- gastroenterology, LUMC, Leiden, dDepartment of Pharmacology, Section Immunology, NV Organon, Oss, eQA/Statistical Department, NV Organon, Oss
  1. Dr K Vos, Department of Rheumatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands Email:kvos{at}rheumatology.azl.nl

Abstract

OBJECTIVE To evaluate plasma human cartilage glycoprotein (HC gp-39) as a possible marker for the presence and/or activity of rheumatoid arthritis (RA) and other inflammatory conditions.

BACKGROUND HC gp-39 is a secretory product of chondrocytes, synovial cells, macrophages, and neutrophils. HC gp-39, also described as YKL-40, was found to be a marker of joint disease and tissue injury in RA and various other diseases.

METHODS Levels of HC gp-39 were determined by a sandwich enzyme linked immunosorbent assay (ELISA) in 47 patients with RA, 47 with osteoarthritis (OA), 24 with systemic lupus erythematosus (SLE), 24 with inflammatory bowel disease (IBD), and in 47 healthy controls. A disease activity score was assessed in the patients with RA, SLE, and IBD.

RESULTS The plasma level of HC gp-39 in the RA patient group was significantly higher than in the other patient groups and healthy controls. The level in patients with OA, SLE, and IBD was also significantly higher than the HC gp-39 level found in the healthy control group. HC gp-39 levels in patients with RA correlated positively with the ESR and IgM rheumatoid factor level but not with other variables of disease activity. In the patients with SLE and IBD no correlation was found with the disease activity score.

CONCLUSION The plasma level of HC gp-39 is increased in inflammatory conditions with and without joint disease (SLE, IBD, OA, and RA). Thus increased levels of HC gp-39 do not only reflect joint disease but also reflect inflammation or tissue degradation in various conditions. Notably, the highest level of HC gp-39 was found in patients with RA. Only in the RA patient group was a correlation between HC gp-39 plasma levels and some laboratory variables of disease activity found.

  • rheumatoid arthritis
  • biochemical markers
  • human cartilage glycoprotein-39
  • YKL-40
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.